spondyloarthropathy (HLA B27-associated arthritis, seronegative spondyloarthropathy)

From Aaushi
Jump to navigation Jump to search

Introduction

A group of disorders that shares clinical features & an association the HLA B-27 allele.

Classification

These disorders include:

Etiology

Epidemiology

  • onset generally < 40 years of age

Genetics

History

Physical examination

Clinical manifestations

Laboratory

Radiology

Management

More general terms

More specific terms

Additional terms

References

  1. Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 1904
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Medical Knowledge Self Assessment Program (MKSAP) 11,15,16,17,18. American College of Physicians, Philadelphia 1998,2009, 2012, 2015, 2018.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  3. Weiner S, In: UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
  4. Rudwaleit M, van der Heijde D, Landewe R et al The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009 Jun;68(6):777-83 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19297344
  5. Maksymowych WP. Progress in spondylarthritis. Spondyloarthritis: lessons from imaging. Arthritis Res Ther. 2009;11(3):222 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19519927
  6. Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res Ther. 2009;11(1):208. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19232062
  7. van Tubergen AM, Landewe RB. Tools for monitoring spondyloarthritis in clinical practice. Nat Rev Rheumatol. 2009 Nov;5(11):608-15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19806152
  8. Rudwaleit M, van der Heijde D, Landewe R et al The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011 Jan;70(1):25-31 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21109520
  9. Poddubnyy D, van der Heijde D. Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs. Rheum Dis Clin North Am. 2012 Aug;38(3):601-11 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23083758
  10. Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012 Aug;38(3):441-76. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23083748
  11. Akdeniz O, Alayli G, Tosun FC et al Early spondyloarthropathy: scintigraphic, biological, and clinical findings in MRI-positive patients. Clin Rheumatol. 2008 Apr;27(4):469-74. Epub 2007 Sep 15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17874171
  12. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017 Jul 1;390(10089):73-84. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28110981
  13. Ehrenfeld M. Spondyloarthropathies. Best Pract Res Clin Rheumatol. 2012 Feb;26(1):135-45. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22424199